# Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED

> **NCT06542276** · NA · ENROLLING_BY_INVITATION · sponsor: **Dunes Eye Consultants** · enrollment: 30 (estimated)

## Conditions studied

- MGD-Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** Thermal Vectored Pulsation

## Key facts

- **NCT ID:** NCT06542276
- **Lead sponsor:** Dunes Eye Consultants
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-09-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-09-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06542276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06542276, "Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06542276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*